Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

Bioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.

Journal of Functional Biomaterials is a prominent peer-reviewed journal dedicated to the innovation and application of biomaterials, covering vital fields such as biomedical engineering and materials science. Published by MDPI in Switzerland, this Open Access journal has been serving the academic community since 2010, allowing unrestricted access to groundbreaking research. With an impressive Q2 ranking in both Biomaterials and Biomedical Engineering for 2023, it stands as a significant contributor to the fields it represents. Researchers will find the journal's focus on functional biomaterials particularly relevant, as it encompasses a diverse range of studies aimed at enhancing the performance and applicability of biomaterials in medical contexts. The journal's commitment to disseminating high-quality research fosters collaboration and innovation among professionals, making it an essential resource for anyone involved in this dynamic area of study.

Gels is a distinguished, peer-reviewed journal published by MDPI, focusing on the innovative field of gels and their myriad applications across disciplines such as bioengineering, biomaterials, and organic chemistry. Since its inception in 2015, this Open Access journal has provided a platform for researchers to disseminate cutting-edge findings, enabling wider visibility and impact for their work. Based in Switzerland, Gels has firmly established itself within the academic community, achieving notable recognition as evidenced by its recent Q1 ranking in Polymers and Plastics, and multiple Q2 placements in related categories, demonstrating its relevance and importance in the field. The journal serves as a vital resource for professionals and scholars aiming to engage with the rapidly evolving research landscape surrounding gel technologies, making significant contributions to sustainable materials, drug delivery systems, and much more. With its commitment to Open Access, Gels ensures that research findings are readily accessible to all stakeholders, fostering collaboration and advancement in science and engineering fields.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for disseminating innovative research in the fields of bioengineering, biomaterials, materials chemistry, and polymers. With an ISSN of 0883-9115 and an E-ISSN of 1530-8030, this journal is committed to the advancement of knowledge relating to the interaction of polymers within biological systems and their compatibility in various applications. Operating since 1986, the journal has garnered a respectable presence, ranked in the Q3 quartile across multiple categories in 2023, indicating its relevance and contribution to these dynamic fields. Although not open access, the journal ensures that high-quality research is accessible to subscribers and institutions, reinforcing its importance for researchers, professionals, and students aiming to stay abreast of advancements in polymer science and biocompatibility. By fostering interdisciplinary communication and collaboration, the JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS continues to play a crucial role in shaping the future of material applications in health, technology, and industry.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.

Advanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.

Tissue Engineering Part C: Methods is a prestigious academic journal published by MARY ANN LIEBERT, INC, specializing in the dynamic and rapidly evolving fields of bioengineering and biomedical engineering. With an ISSN of 1937-3384 and E-ISSN 1937-3392, this journal provides a platform for the dissemination of cutting-edge research from 2008 to 2024, showcasing methodologies that advance the science of tissue engineering. Ranked in the second and third quartiles across several categories in 2023, including a notable Q2 in Biomedical Engineering, the journal is recognized for its contributions to the interface of biology and engineering. Additionally, it holds commendable Scopus ranks that highlight its influence and reach within the scientific community. Although it does not offer open access, the journal remains vital for researchers, professionals, and students seeking insightful articles that bridge the gap between theoretical research and practical application in tissues and regenerative medicine. With its rigorous peer-review process and commitment to quality, Tissue Engineering Part C: Methods continues to be an essential resource for those at the forefront of tissue engineering innovations.